Diagnostic anti-Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) antibodies pairs and antigens for animal health (animal infectious disease ) testing in ELISA test,competitive ELISA test, blocking ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), and immunonephelometry

Catalog Number: GMP-AD-Pet-4

Definition of the disease: Canine adenovirus type 2 (CAV-2) is related to the hepatitis virus, canine adenovirus type 1 (CAV-1). CAV-2 is used in vaccines to provide protection against canine infectious hepatitis. CAV-2 is also one of the causes of infectious tracheobronchitis, also known as canine cough.

Genemedi produces core animal health diagnostic ingredients-validated antibodies pairs Mouse anti-Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) monoclonal antibodies and Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) antigens for rapid test kit of animal infectious disease with Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) to evaluate the animal health of Pet.

The paired antibodies are both monoclonal antibody(mab).

All the antibodies and antiges of animal disease test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibody can act as a capture antibody and detection antibody. Antigens are validated as positive control materials.

Order information

Catalog No.
(1~4, 4 antibodies in pairs)		 Size Price(In USD) Qty (Quantity) Sum(In USD)
GMP-AD-Pet-4Ab-1 Size:1mg 3090
GMP-AD-Pet-4Ab-1 Size:10mg 21935
GMP-AD-Pet-4Ab-1 Size:100mg 148000
GMP-AD-Pet-4Ab-2 Size:1mg 3090
GMP-AD-Pet-4Ab-2 Size:10mg 21935
GMP-AD-Pet-4Ab-2 Size:100mg 148000
GMP-AD-Pet-4Ab-3 Size:1mg 3090
GMP-AD-Pet-4Ab-3 Size:10mg 21935
GMP-AD-Pet-4Ab-3 Size:100mg 148000
GMP-AD-Pet-4Ab-4 Size:1mg 3090
GMP-AD-Pet-4Ab-4 Size:10mg 21935
GMP-AD-Pet-4Ab-4 Size:100mg 148000
GMP-AD-Pet-4Ag-1 Size:1mg 3090
GMP-AD-Pet-4Ag-1 Size:10mg 21935
GMP-AD-Pet-4Ag-1 Size:100mg 148000
GMP-AD-Pet-4Ag-2 Size:1mg 3090
GMP-AD-Pet-4Ag-2 Size:10mg 21935
GMP-AD-Pet-4Ag-2 Size:100mg 148000
Shipping Cost: 760.00
Total:

For more than 100mg, click here for inquiry. >>


Description


GMP-AD-Pet-4Ab, GMP-AD-Pet-4Ag

Cat No. GMP-AD-Pet-4Ab
Antigens Canine adenovirus type 2 (CAV-2，CAV-Ⅱ)
Antibody Mouse anti-Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) monoclonal antibodies
Resource (expression host) hybridoma
Specics/Isotypes Mouse IgG
Bioactivity validation Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) level test and Pet-diagnositcs.
Antigen description A candidate vaccine virus (CVV) is an influenza (flu) virus that has been prepared by CDC or another public health partner that can be used by vaccine manufacturers to produce a flu vaccine. In addition to preparing CVVs for seasonal flu vaccine production, CDC routinely develops CVVs for novel avian influenza (bird flu) viruses with pandemic potential as part of pandemic preparedness activities. Some novel bird flu viruses with pandemic potential are “highly pathogenic avian influenza” (HPAI) viruses, which means they are deadly to domestic poultry, including chickens. Data collected through global and animal flu surveillance informs the selection of CVVs, and experts choose CVVs against bird flu viruses in nature (“wild type” viruses) that pose a risk to human health.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, Lateral flow immunoassay (LFIA), and other immunoassays;
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Cat No. GMP-AD-Pet-4Ag
Antigens Canine adenovirus type 2 (CAV-2，CAV-Ⅱ)
Resource (expression host) E.coli
Specics/Isotypes Canine adenovirus type 2 (CAV-2，CAV-Ⅱ)
Bioactivity validation Antibody Binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays in Canine adenovirus type 2 (CAV-2，CAV-Ⅱ) level test and Pet-diagnositcs.
Tag His
Antigen description A candidate vaccine virus (CVV) is an influenza (flu) virus that has been prepared by CDC or another public health partner that can be used by vaccine manufacturers to produce a flu vaccine. In addition to preparing CVVs for seasonal flu vaccine production, CDC routinely develops CVVs for novel avian influenza (bird flu) viruses with pandemic potential as part of pandemic preparedness activities. Some novel bird flu viruses with pandemic potential are “highly pathogenic avian influenza” (HPAI) viruses, which means they are deadly to domestic poultry, including chickens. Data collected through global and animal flu surveillance informs the selection of CVVs, and experts choose CVVs against bird flu viruses in nature (“wild type” viruses) that pose a risk to human health.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, Lateral flow immunoassay (LFIA), and other immunoassays;
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -105℃ under sterile conditions. Avoid repeated freeze-thaw cycles.